CHARLESTON An official of the U.S. Drug Enforcement Administration told attorneys defending suppliers of opioid drugs that the companies were supposed to protect against suspicious drug orders without specific guidance from the DEA.
CHARLESTON — Opioid manufacturers’ compliance with the federal Controlled Substances Act depended heavily on the judgment, diligence and action of compliance executives and other employees at those companies, according to
CHARLESTON – Attorneys defending drug suppliers accused of creating an opioid epidemic in West Virginia sought to poke holes in the earlier testimony of an analyst called as an expert witness by the state whose numbers showed a dramatic increase in opioid prescriptions from the years 2007 to 2017.
CHARLESTON — Counsel for the two remaining defendants in West Virginia’s ongoing opioid litigation spent Tuesday breaking down testimony from Dr. Andrew Kolodny, an expert witness called by the state,
CHARLESTON — Katherine Keyes, a professor of epidemiology at the Columbia University Mailman School of Public Health, testified Tuesday that high exposure and easy access to prescription opioids were the